Abstract-Dozens of drug terminologies and resources capture drug and/or drug class information; they range greatly in their coverage and their adequacy of representation. However, there are no transformative ways to link these resources together in a standard and formal fashion, which hinders data integration and data representation for supporting drug-related clinical and translational studies. In this study, we generated a standardized Pharmacological Class Profile Ontology, named PCPO, which integrates multiple drug resources in the Web Ontology Language (OWL). More specifically, we mapped two well-known drug class resources, Anatomical Therapeutic Chemical classification system (ATC) and National Drug File Reference Terminology (NDF-RT), as the pharmacological class backbone. Furthermore we extended the PCPO with individual clinical drug information extracted from RxNorm and Structured Product Labeling. In parallel, we calculated and compared chemical structure similarity for each drug pair from ATC and NDF-RT, and re-grouped drugs with a similar structure into a same drug class. PCPO will not only present big drug data into well-organized formal form, OWL with possible inference capability, but also potentially support computational drug repurposing application development.
I. BACKGROUND
Drugs can be classified into different groups on the basis of their active chemical ingredients or therapeutic effects on patients. For instance, the Anatomical Therapeutic Chemical classification system (ATC) [1] groups drugs according to the organ or system, on which they act and their therapeutic, pharmacological and chemical properties. The National Drug File Reference Terminology (NDF-RT) [2] groups drugs using their dominant mechanism of action. These 2 drug resources provide comprehensive drug classification information. They are, however, incompatible because of the drug representations (ATC uses ACT code; NDF-RT uses NDF-RT Unique Identifier [NUI] ) and the different data formats (ATC is represented in Excel files; NDF-RT is in Web Ontology Language [OWL] ) .Such incompatibility issues hinder data sharing and reuse among different drug class resources.
A few previous research efforts have explored different drug resources and represented them in a same form. Hanna et al [3] built a Drug Ontology (DrOn) by exploring drug data from RxNorm and Chemical Entities of Biological Interest (ChEBI) in a consistent form. Mougin et al [4] compared drug classes between ATC and NDF-RT, focusing on the relationships between drugs and pharmacological classes (ie, drug-class membership relationships). Mortensen and Bodenreider [5] evaluated pharmacologic classes for NDF-RT with SNOMED-CT (Systematized Nomenclature of MedicineClinical Terms) and MeSH by comparing drug class in a same form and comparing drug class members by using Jaccard coefficient. These studies facilitate drug data integration via individual drug and pharmacologic class mapping. None of them, however, made efforts toward integration with individual drugs and drug classes in a formal drug representation by using OWL to further support development of computational drug applications. Therefore, the aim of this study was to represent a huge volume of drug and drug class information from diverse resources in a centralized, standard and integrated manner for further inference supported by Semantic Web Technologies (SWT). With recent advances in web technologies, SWT can manage complex scientific data in a more integrative and intelligent fashion. OWL, as a Semantic Web standard (W3C recommendation), can formally represent domain knowledge and has a mechanism for specifying taxonomies of the classes and properties.
In the current study, we developed an approach to map drug and drug class entities from ATC and NDF-RT to construct a drug class backbone via Unified Medical Language System (UMLS) [6] . Furthermore, we extended the drug classes with individual drugs extracted from RxNorm [7] and Structured Product Labeling (SPL) [8] . Additionally, to extend and compare the drug classes derived from ATC and NDF-RT from a chemical structure perspective, we introduced chemical structure similarity, with the assumption that similar molecules have similar activities, to group drugs into drug classes with similar chemical structures. We further represented drug mappings in OWL to create a Pharmacological Class Profile Ontology (PCPO) to capture integrative drug class and individual drug information. The OWL representation not only formalizes pharmacological class expressions but also enables semantic reasoning capacities for novel drug-relevant knowledge discovery.
II. MATERIALS

A. National Drug File Reference Terminology
NDF-RT [2] is a well-known drug terminological resource, which is used for modeling drug characteristics, including ingredients, dose forms, diseases, Legacy Veterans Affairs (VA) classes and External Pharmacologic classes (EPCs), VA products, chemical ingredients, and generic ingredient combinations. NDF-RT was explored and used in this study, with 48,266 NDF-RT concepts in the snapshot downloaded as of November 8, 2012 .
B. Anatomical Therapeutic Chemical Classification System
ATC [1] is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology. In ATC, drugs are categorized into different groups at 5 different levels, according to the organ or system on which they act and/or their therapeutic and chemical characteristics. The first level is formed by 14 anatomical main groups, the second level consists of 94 therapeutic main groups, the third level consists of 267 pharmacological/therapeutic subgroups, the fourth level consists of 878 pharmacological/therapeutic subgroups, and the fifth level consists of 4,464 drugs. The January 2012 release version of ATC was used in this study.
C. RxNorm
RxNorm [7] provides normalized names for clinical drugs and links them to several drug vocabularies, differentiating by "SAB" label. For example, "SAB=MTHSPL" indicates the source from SPL and "SAB=NDFRT" from NDF-RT. Two RxNorm files (October 2012 version) were used in this study: 1) RXNCONSO.RRF, including all connections with source vocabularies and 2) RXNREL.RRF, including relationships among concepts. RxNorm provides links among different vocabularies (eg, NDF-RT).
D. Structured Product Labelling
The SPL [8] standard has been adopted by the US Food and Drug Administration for exchanging information about drugs and drug ingredients, including dosage, strength, usage, and known adverse drug events [9] . SPL relevant applications have been developed, such as LinkedSPLs [10] and ADEPedia [11] . With these existing SPL resources, it will be feasible for us to integrate more SPL information into our drug class profiles linking to adverse drug event (ADE), drug drug interaction (DDI). SPL contains structured content of labeling (sections, tables, and figures), along with unstructured section content (all text). To avoid dealing with unstructured text in this study, we extracted mappings between SPL and NDF-RT, and RxNorm from RxNorm RXNCONSO files with "SAB=MTHSPL."
E. Unified Medical Language System
UMLS [6] is a collection of files and software that aggregates many health and biomedical vocabularies and standards to enable interoperability between computer systems. UMLS as an intermediate standard identifier has been used in different studies [4, 12] for data integration, with good performance. In this study, we will also map ATC drugs to NDF-RT via UMLS as the intermediate identifier.
F. Web Ontology Language
OWL, as a Semantic Web standard (W3C recommendation), is "a family of knowledge representation languages for authoring ontologies" [13] , and it "organizes concepts or entities within classification (specialization or "isa") hierarchies that provide for inheritance of attributes" [14] . We represented pharmacological class profiles in OWL.
III. METHODS
A. PCPO Development
We generated the PCPO by linking drug concepts from different drug resources in two layers, drug class layer and individual drug layer. For drug concept mappings among RxNorm, SPL, and NDF-RT, we directly extracted these mappings from 2 RxNorm files, RXNCONSO and RXNREL, and loaded them into the MySQL database. Figure 1 shows the workflow of the PCPO generation, along with relationships expressed in the PCPO. Details of each step in the process are described in the following sections. 
B. Mapping between NDF-RT and ATC
• ATC Mapping to UMLS: We used NCBO Annotator [15] to semantically annotate each ATC drug entity. To avoid unexpected annotations by non-drug-relevant ontologies, we limited UMLS semantic types [16] belonging to the "Chemicals & Drugs" semantic group [17] as input parameters for the annotator. Among more than 200 ontologies from UMLS Metathesaurus and NCBO, RxNorm and NDF-RT have been assigned higher priority in this present study. From the annotation results, we extracted ontology ID and concept ID as 2 mandatory input parameters to invoke the NCBO BioPortal REST application programming interface (API) [18] for UMLS mappings, along with UMLS concept unique identifier (CUI).
• NDF-RT Mapping to RxNorm and UMLS: NDF-RT concepts are classified into different categories with corresponding category labels. For example, "N0000179008, 1,1,1-trichloroethane, [Chemical/Ingredient]" and "N0000175641, Autonomic Ganglionic Blocker, [EPC]" indicate that 2 NDF-RT concepts belong to "chemical ingredient" and "EPC" respectively. In this study, we retrieved concepts that were labeled as VA class, VA product, EPC, chemical ingredient, and generic ingredient combination. We queried NUIs against the getConceptsByProperty function via RxNav REST API [19] to retrieve UMLS CUIs by specifying "UMLS_CUI" as the input property parameter. The mappings between NDF-RT and RxNorm exist in the RxNorm RXNCONSO table, and SQL querying was executed to search for RxNorm CUIs from the RXNCONSO table for given NUIs. ATC and NDFRT concepts with same UMLS CUIs have been mapped.
• Calculating Structural Similarity: Drugs with similar chemical structure are very likely to share the same biological properties [20] . Thus, we calculated structural similarities among drug pairs from ATC and NDF-RT, and grouped them by structural similarity. The cutoff value for structural similarity was set as greater than 0.85. We first converted NDF-RT drug names and ATC names to SMILES (simplified molecular-input lineentry system) [21] as chemical representation by invoking PubChem Entrez web service [22] and the National Cancer Institute (NCI) resolver REST API [23] . We then translated a unique list of SMILES generated from the above 2 web APIs to chemical fingerprint. We applied 2 functions, getFingerprint and Tanimoto.calculate, from the Chemistry Development Kit [24] to generate an array of 166 binary descriptors that consist of "presence" (denoted as 1) or "absence" (denoted as 0) of the common 2-dimensional structural features existing in a chemical, as defined by MACCS structural keys [25] , and calculated Tanimoto coefficient (ie, similarity between these pairs of descriptors) [26) , respectively. The Tanimoto coefficient between 2 chemicals a and b is defined as:
where Nc is the number of bits that are set in the fingerprints for both a and b, and Na and Nb are the total number of bits set in a and b, respectively.
C. Mapping between RxNorm and SPL
To integrate individual clinical drugs, we imported mappings among RxNorm, SPL, and NDF-RT, which are available in the RxNorm RXNCONSO table. To retrieve these mappings, we first obtained concepts labeled as "SAB=NDFRT" and "SAB=RXNORM," denoted as RxNorm and NDF-RT mappings. Then, we searched for the concepts with the "SAB=MTHSPL" label from the concepts identified in the first step. The final list of concepts encompasses the common concepts across the 3 resources. We extracted SPL identifiers (setId) from the RXNREL table and saved them for further integration of SPL-relevant resources.
D. PCPO Representation in OWL
We applied an ontology-based method to represent the mappings among heterogeneous drug terms/concepts in the PCPO. To ensure semantic interoperability, the PCPO imports existing drug ontologies. For ATC, we adopted the ontology developed by Croset et al [27] ; for NDF-RT, we used the ontology released by the NIH [28] , and for RxNorm, we used the OWL/RDF file exported from the NCBO BioPortal [29] . There is no OWL representation of SPL at this time, so we have not represented the mappings to SPL semantically in the PCPO. We defined a new OWL class for each unique drug term in the mappings generated previously. For mappings between ATC and NDF-RT, we first created a new OWL class with a PCPO URI (Uniform Resource Identifier) for each unique ATC drug entity. This OWL class will then be defined as an equivalent class of the corresponding mapped NDF-RT OWL classes of this ATC class to indicate the mapping between ATC and NDF-RT. One ATC drug entity could be mapped to multiple NDF-RT drug entities. For instance, one particular ATC drug entity, "A01AA01-sodium fluoride" can be mapped to 2 NDF-RT drug concepts, "N0000007218-Sodium Fluoride-Chemical/Ingredients" and "N0000146042-SODIUM FLUORIDE-Generic Ingredient Combination". In OWL, if we define that "A01AA01" is an equivalent class of both "N0000007218" and "N0000146042" then the reasoner will infer that "N0000007218" is an equivalent class of "N0000146042", which is not necessarily true from the NDF-RT perspective because they are defined as two individual NDF-RT concepts. To avoid such inappropriate reasoning by OWL, we selected NDF-RT concepts with "Generic Ingredient Combination" as the role of "Drug Kind" including annotated drug properties, instead of "Chemical/Ingredients" as "Ingredients Kind". The "Chemical/Ingredients" concepts can be tracked back from "Generic Ingredient Combination" concepts via the "has_ingredient" property. For NDF-RT to RxNorm mappings, we specified that an RxNorm concept (OWL class) is a subclass of a mapped NDF-RT concept (OWL class) accordingly. This way, the PCPO contains higher-level drug classifications derived from both ATC and NDF-RT and lower-level information about individual clinical drugs from RxNorm. We represented structural similarity between pairs of drugs in the PCPO. Because OWL only supports binary relationships, we followed the World Wide Web Consortium guidelines [30] and introduced a new class called "Similarity" to represent the target drug and the corresponding similarity score. In the example shown in Figure 2 , we defined that the similarity score between Drug1 and Drug2 is 0.98. We used the OWL "somevaluesfrom" restriction to define the relationship between Drug1 and an anonymous node, which is defined as a subclass of Similarity that "isStructuralSimilarTo" some Drug2 and "hasSimilarityScore" 0.98. 
IV. RESULTS
A total of 5,717 ATC drug entities are included in this study, which corresponds to 4,483 distinct ATC terms. That is, one drug can be categorized into multiple therapeutic classes. Of the 48,266 NDF-RT concepts, 34,011 concepts were used in this study, consisting of 15,857 VA products, 486 VA classes, 9,960 Chemical/Ingredients, 7,184 Generic Ingredient Combinations, and 524 EPCs.
A. ATC and NDF-RT Mapping
ATC Annotated by NCBO：A total of 3,607 ATC entities, including 3,152 drugs and 455 drug classes, were mapped to UMLS CUIs via NCBO BioPortal (Figure 3 ). Of these 3,607 ATC mappings, 2,180 ATC entities were exactly matched with the preferred names from RxNorm and NDF-RT. In addition, 866 ATC entities, including 211 drug classes and 655 drugs, were mapped to other ontologies available from NCBO. A total of 1,244 ATC entities (21.8% of 5,717), including 657 drugs and 587 drug classes, failed to map to UMLS because no annotations were generated accordingly. We attempted to map these failed ATC names with RxNorm directly by invoking the National Library of Medicine (NLM) RxNav RESTful API [31] with ATC names as the input parameter, but none of them got mapping results.
• NCBO Annotation Evaluation: Annotations were programmatically performed using NCBO Annotator Web Services API. We manually evaluated the annotation results. Of the 4,473 annotations with NDF-RT and RxNorm, 2,401 exact mappings were skipped to further evaluation. Two authors (Q.Z., C.T.) manually reviewed the rest of the annotations (n=2,072). The evaluation showed 88.7% correct mappings (n=1,838), 10.3% partial mappings (n=214), and 1.0% incorrect mappings (n=20). The precision was 99.5%, recall was 78.2%, and the F-measure was 87.4%, in which we counted exact mappings, partial mappings, and semantically correct mappings (n=4,453) as true-positive, 1,244 failed mappings as false-negative, and 20 incorrect mappings as falsepositive ( Figure 3 ).
• ATC and NDF-RT Mapping: ATC and NDF-RT were mapped via UMLS as intermediate identifiers.
Mappings between NDF-RT and UMLS were retrieved by invoking RxNav NDF-RT API. In total, 3,850 distinct mappings between ATC and NDF-RT were generated, including 2,015 Chemical/Ingredients, 1,826 Generic Ingredient Combinations, and 1 VA class. It includes 2,226 distinct ATC entities, covering 99 drug classes and 2,127 individual drugs.
• Structural Similarity Calculation: To calculate structural similarity, we retrieved SMILES for drugs from ATC and NDF-RT via PubChem Entrez web API [32] and NCI Resolver web API [23] . SMILES were retrieved for 2,618 ATC entities from NCI, and 3,471 entries were retrieved from PubChem. Combining NCI and PubChem search results, 3,487 ATC entries retrieved SMILES, and 9,132 unique NDF-RT concepts retrieved SMILES. We calculated the Tanimoto coefficient based on the fingerprint converted from SMILES as structural similarity for pairs of concepts from ATC and NDF-RT separately. We found 8,513 pairs from ATC and 69,882 pairs from NDF-RT with a Tanimoto coefficient greater than 0.85, and then integrated them into the drug class network.
B. NDF-RT, RxNorm, and SPL Mapping
We integrated RxNorm and SPL mappings with NDF-RT. The mappings between RXNORM, NDF-RT, and SPL resulted in 5,838 unique RxNorm concepts, with 36,408 NDF-RT concepts and 41,188 SPL labels. The mappings mostly fall into 2 main categories according to term types defined by RxNorm: 3,056 are Semantic Clinical Drugs and 1,543 are Ingredients. Of note, one RxNorm concept may be mapped to multiple NDF-RT and/or SPL concepts. For example, RxCUI "74" mapped to 3 NUIs in NDF-RT, including N0000006481, N0000147349, and 11 set_ids in MTHSPL, such as 0d65128b-8eb7-440b-870a-7e3be18152b3 and 1e6d6cd5-ab14-4258-a0fe-5f6a3cae437f.
C. PCPO Ontology
The PCPO, which can be accessed at https://sourceforge.net/projects/PCPO/, currently contains 58,241 OWL classes, 98,677 subclass axioms, and 21,917 equivalent class axioms. It has defined 178,838 axioms with 120,594 logical axioms.
D. Case Study for Drug Profile Generation
We generated a drug profile for medrysone, which "is indicated for the treatment of allergic conjunctivitis" [22] , to evaluate the PCPO and demonstrate its usability. This drug profile provides comprehensive drug and drug class information particularly for medrysone via drug mappings and semantic inference available from the PCPO. "S01BA08" (medrysone), an ATC entry, is grouped into a category "S02BA" (Corticosteroids, plain), which is linked to "S01B" (ANTIINFLAMMATORY AGENTS), "S01" (OPHTHALMOLOGICALS) and "S" (SENSORY ORGANS). Besides the drug classification information from the ATC, more connections can be identified via direct and indirect drug and phenotype linkages to medrysone from the PCPO. Medrysone's drug profile is shown in Figure 4 (please check it in the last page). In the PCPO, medrysone has mapped to one SPL label, which provides more drug information from the drug label sections. Mapping to RxNorm offers detailed clinical drug information. In addition to drug class information, NDF-RT includes annotated clinical relationships. Structural similarity can be used to discover new connections for medrysone from a chemical structural perspective. Relevant new connections are added into the PCPO if the structures of the corresponding classes (structures) are similar. Figure 5 illustrates new drug connections discovery for medrysone from the PCPO. The pathway shown in this figure is starting from the ATC network to the PCPO generation and then drug connection discovery for medrysone. The network shown in the figure is visualized by Cytoscape [33] . Within this network, the nodes are represented as drugs or drug classes, and the nodes are connected when child and parent relationships are present in the PCPO or the structural similarity between 2 nodes is greater than 0.8.
V. DISCUSSION
In this study, we successfully built pharmacological class profiles with 39,728 concepts from ATC and NDF-RT. We integrated RxNorm and SPL mappings, and extended the drug classes with structural similarity calculation.
A. ATC to UMLS Mapping
In total, 77.9% of ATC terms were mapped to UMLS. Compared with the 68.7% mapping results in a study by Merabti et al [34] , our study shows an improvement in mappings from ATC to UMLS by leveraging NCBO Annotator. However, 22.1% of ATC terms failed to be mapped for several possible reasons. First, many of the ATC terms are combinations of multiple concepts, such as "calcium acetate and magnesium carbonate," or "combinations of sulfonamides and trimethoprim, including derivatives", which are unable to be mapped; Second, the exclusions are embedded in the ATC names, such as "platelet aggregation inhibitors excluding heparin," or "nutrients without phenylalanine." Third, nonstandard representation is used by ATC, although we corrected and expanded some abbreviations occurring in ATC names. For example, "DIGESTIVES, INCL. ENZYMES" was corrected to "DIGESTIVES, INCLUDING ENZYMES." Fourth, nondrug terms are used in ATC, especially for drug classes, such as "VARIOUS" or "SENSORY ORGANS." In future studies, we will explore the MMTx program reported by Mougin et al [4] and other natural language processing algorithms to parse ATC names to improve the mapping performance between ATC and UMLS.
B. NDF-RT and RxNorm and SPL Mappings
RxNorm and SPL mappings with NDF-RT were performed by searching concepts directly from the RXNCONSO table using the source information (eg, SAB=RXNORM, SAB=NDFRT, and SAB=MTHSPL), because such mappings have already been integrated by RxNorm. During the mapping process, we noticed that many connections with other sources from RxNorm were not fully applied to enhance the mapping via inferring the term types, as demonstrated in other studies [35] . For example, the RxNorm concept "Parlodel" is not mapped to NDF-RT currently, but its precise ingredient (2-bromoergocryptine mesylate) does map to NDF-RT. To fill this gap, we will expand the mapping between RxNorm and NDF-RT and other sources by traversing the relationships from RxNorm.
C. Benefits of Structural Similarity Integration
The structural similarity calculations applied in this study enable connections to be made among drug nodes sharing similar common chemical substructures. Besides the benefit gained from the case study, such integration provides relevant clues for guiding clinical decision support from a structural perspective. ATC categorizes drugs according to therapeutic classes; hence, one ATC drug can be grouped into multiple categories on the basis of its diverse therapeutic functions. For instance, "thonzylamine" is an antihistamine and anticholinergic used as an antipruritic and is grouped into 2 categories: "antiallergic agents" and "antihistamines for topical use" within the ATC hierarchy. The corresponding 2 ATC entities (R01AC06 and D04AA01) for "thonzylamine" in 2 separate classes ("R" and "D") are connected based on a similarity score of 1. Thus, the entities within these 2 categories are connected, and it's possible that physicians can retrieve such knowledge about thonzylamine from both therapeutics and structural points of view. In this study, we only calculated similar drugs from ATC and NDF-RT individually, and we will identify and include similar drug pairs from both ATC and NDF-RT.
D. NDF-RT Enhancement with ATC and RxNorm Via OWL Representation
The NLM has made much progress leveraging several drug terminologies to enhance NDF-RT coverage; more specifically, NDF-RT has integrated mappings with MeSH, RxNorm, and UMLS as class labels defined in the OWL version. However, class labels are unable to inherit existing knowledge from integrated resources via OWL reasoning. In our study, we defined mapped ATC entities as equivalent classes with NDF-RT classes and mapped RxNorm concepts as subclasses of NDF-RT classes. In other words, drug classes were defined as upper level and individual drugs as lower level in OWL. Thus, we will not only transform information in the same level but also provide comprehensive drug class profiles for individual drugs through inheritance from upper-integrative drug class levels.
VI. CONCLUSIONS
We successfully integrated NDF-RT, ATC, RxNorm, and SPL and built pharmacological class profiles for representing drug and drug class entities. In addition, the profiles were expanded from a chemical structure perspective by similarity calculation. The profiles were converted and expressed as OWL ontology to support automatic reasoning, which can ultimately be used for drug repositioning. We have also demonstrated the usability and performance of PCPO with a case study. To expand the coverage and usage of PCPO, other drug terminological resources and drug interaction information will be integrated in the future. The subnetwork for "S01BA08" (medrysone) taken from the ATC class is enlarged at upper middle. The enlarged subnetwork integrated with structural similarity is shown at lower right. The ATC pairs list shown in the lower left includes all adjacent edges for "S01BA08." These pairs correspond to the edges in red in the network shown at the lower right, and the node in yellow shown at the upper right and lower right is "S01BA08." The structures of medrysone and hydrocortisone are shown in the upper right corner. A total of 19 connections, including "D07XA01" (hydrocortisone), have been generated for "S01BA08" (medrysone) using structural similarity calculation; the similarity between "D07XA01" and "S01BA08" is 0.92. Some other connections, including the mappings between ATC and NDF-RT, are listed in the lower left corner.
